In vitro effects of methotrexate on human articular cartilage and bone-derived osteoblasts

British Journal of Rheumatology

Volumn 35, Issue 4, 1996, Pages 342-349

  Van Der Veen, M J ^a   Scheven, B A A ^a,b   Van Roy, J L A M ^a   Damen, C A ^a   Lafeber, F P J G ^a   Bijlsma, J W J ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b ROWETT RESEARCH INSTITUTE   (United Kingdom)

Author keywords

Cartilage; Methotrexate; Osteoblasts; Rheumatoid arthritis

Indexed keywords

FOLIC ACID ANTAGONIST; INTERLEUKIN 1; METHOTREXATE; PROTEOGLYCAN;

ADULT; AGED; ARTICLE; ARTICULAR CARTILAGE; BONE DESTRUCTION; CARTILAGE DEGENERATION; CLINICAL ARTICLE; HUMAN; HUMAN TISSUE; MONONUCLEAR CELL; OSTEOBLAST; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; TISSUE CULTURE;

EID: 0029939383     PISSN: 02637103     EISSN: None     Source Type: Journal    
DOI: 10.1093/rheumatology/35.4.342     Document Type: Article

References (42)

1. Weinblatt ME, Kaplan H, Germain BF et al. Methotrexate in rheumatoid arthritis: effects on disease activity in a multicenter prospective study. J Rheumatol 1991;18:334-8.
2. Andersen PA, West SG, O'Dell JR, Via ChS, Claypool RG, Kotzin BL. Weekly pulse methotrexate in rheumatoid arthritis. Ann Intern Med 1985;103:489-96.
3. Olsen NJ, Murray LM. Antiproliferative effects of methotrexate on peripheral blood mononuclear cells. Arthritis Rheum 1989;32:378-85.
4. Johnson WJ, DiMartino MJ, Meunier PC, Muirhead KA, Hanna N. Methotrexate inhibits macrophage activation as well as vascular and cellular inflammatory events in rat adjuvant induced arthritis. J Rheumatol 1988;15:745-9.
5. Ridge SC, Ferguson KM, Rath N et al. Methotrexate suppresses passive adjuvant arthritis: studies on the metabolism of methotrexate in mononuclear cells derived from normal and adjuvant- arthritic rats. J Rheumatol 1988;15:1193-7.
6. O'Callaghan JW, Forrest MJ, Brooks PM. Inhibition of neutrophil chemotaxis in methotrexate-treated rheumatoid arthritis patients. Rheumatol Int 1988;8:41-5.
7. 4 and complement C5a. J Rheumatol 1987;14:9-11.
8. Asako H, Kubes P, Baethge BA, Wolf RE, Granger DN. Colchicine and methotrexate reduce leukocyte adherence and emigration in rat mesenteric venules. Inflammation 1992;16:45-56.
9. Hine RJ, Everson MP, Hardin JM et al. Methotrexate therapy in rheumatoid arthritis patients diminishes lectin-induced mononuclear cell proliferation. Rheumatol Int 1990;10:165-9.
10. Hopkins SJ, Humphreys M, Jayson MIV. Cytokines in synovial fluid: I. The presence of biologically active and immunoreactive IL-1. Clin Exp Immunol 1988;72:422-7.
11. Hopkins SJ, Meager A, Cytokines in synovial fluid: II. The presence of tumour necrosis factor and Interferon. Clin Exp Immunol 1988;73:88-92.
12. Wilbrink B, Nietfeld JJ, Den Otter W, Van Roy JLAM, Bijlsma JWJ, Huber-Bruning O. Role of TNFα, in relation to IL-1 and IL-6 in the proteoglycan turnover of human articular cartilage. Er J Rheumatol 1991;30:265-71.
13. Shore A, Jaglal S, Keystone EC. Enhanced interleukin 1 generation by monocytes in vitro is temporally linked to an early event in the onset or exacerbation of rheumatoid arthritis. Clin Exp Immunol 1986;65:293-302.
14. Danis VA, March LM, Nelson DS, Brooks PM. Interleukin-1 secretion by peripheral blood monocytes and synovial macrophages from patients with rheumatoid arthritis. J Rheumatol 1987;14:33-9.
15. Chang D-M, Weinblatt ME, Schur PH. The effects of methotrexate on interleukin 1 in patients with rheumatoid arthritis. J Rheumatol 1992;19:1678-82.
16. Rau R, Herborn G, Karger T, Werdier D. Retardation of radiologic progression in rheumatoid arthritis with methotrexate therapy: a controlled study. Arthritis Rheum 1991;34:1236-44.
17. López-Méndez A, Daniel WW, Reading JC, Ward JR, Alarçon GS. Radiographic assessment of disease progression in rheumatoid arthritis patients enrolled in the cooperative systematic studies of the rheumatic diseases program randomized clinical trial of methotrexate, auranofin, or a combination of the two. Arthritis Rheum 1993;36:1364-9.
18. Nordstrom DM, West SG, Andersen PA, Sharp JT. Pulse methotrexate therapy in rheumatoid arthritis. A controlled prospective roentgenographic study. Ann Intern Med 1987;107:797-801.
19. Kremer JM, Lee JK. A long-term prospective study of the use of methotrexate in rheumatoid arthritis. Update after a mean of fifty-three months. Arthritis Rheum 1988;31:577-84.
20. Weinblatt ME, Polisson R, Blotner SD et al. The effects of drug therapy on radiographic progression of rheumatoid arthritis. Results of a 36-week randomized trial comparing methotrexate and auranofin. Arthritis Rheum 1993;36:613-9.
21. Jeurissen MEC, Boerbooms AMTh, van de Putte LBA, Doesburg WH, Lemmens AM. Influence of methotrexate and azathioprine on radiologic progression in rheumatoid arthritis. A randomized, double-blind study. Ann Intern Med 1991;114:999-1004.
22. Alarcon GS, López-Méndez A, Walter J et al. Radiographic evidence of disease progression in methotrexate treated and nonmethotrexate disease modifying antirheumatic drug treated rheumatoid arthritis patients: a meta-analysis. J Rheumatol 1992;19:1868-73.
23. Ragab AH, Frech RS, Vietti TJ. Osteoporosis fractures secondary to methotrexate therapy of acute leukemia in remission. Cancer 1970;25:580-5.
24. Preston SJ, Diamond T, Scott A, Laurent MR. Methotrexate osteopathy in rheumatic disease. Ann Rheum Dis 1993;52:582-5.
25. Lafeber FPJG, Van Roy JLAM, Wilbrink B, Huber-Bruning O, Bijlsma JWJ. Human osteoarthritic cartilage is synthetically more active but in culture less vital than normal cartilage. J Rheumatol 1992;19:123-9.
26. Lafeber FPJG, Van der Kraan PM, Van Roy JLAM, Huber-Bruning O, Bijlsma JWJ. Articular cartilage explant culture; an appropriate in vitro system to compare osteoarthritic and normal human cartilage. Connect Tissue Res 1993;29:287-99.
27. Whiteman P. The quantitative measurement of alcian blue-glycpsaminoglycan complexes. Biochem J 1973;131:343-50.
28. Lafeber FPJG, Van der Kraan PM, Van Roy JLAM et al. Local changes in proteoglycan synthesis during culture are different for normal and osteoarthritic cartilage. Am J Pathol 1992;140:1421-9.
29. Scheven BAA, Damen CA, Hamilton NJ, Verhaar HJJ, Duursma SA. Stimulatory effects of estrogen and progesterone on proliferation and differentiation of normal human osteoblast-like cells. Biochem Biophys Res Commun 1992;186:54-60.
30. Oliver MH, Harrison NK, Bishop JE. A rapid and convenient assay for counting cells cultured in microwell plates: application for assessment of growth factors. J Cell Sci 1989;92:513-8.
31. Arnett FC, Edworthy SM, Bloch DA et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-23.
32. Scheven BAA, Van der Veen MJ, Damen CA et al. Effects of methotrexate on human osteoblasts in vitro: Modulation by 1,25-dihydroxyvitamin D3. J Bone Min Res 1995;10:874-80.
33. Tishler M, Caspi D, Graff E, Segal R, Peretz H, Yaron M. Synovial and serum levels of methotrexate during methotrexate therapy of rheumatoid arthritis. Br J Rheumatol 1989;28:422-3.
34. Nietfeld JJ, Wilbrink B, Den Otter W, Huber J, Huber-Bruning O. The effect of human interleukin-1 on human and porcine cartilage explants. J Rheumatol 1990;17:818-26.
35. Tyler JA, Bolis S, Dingle JT, Middleton JFS. Mediators of matrix catabolism. In: Kuettner KE, ed. Articular cartilage and osteoarthritis. New York: Raven Press, 1992:251-64.
36. Wilbrink B, Holewijn M, Bijlsma JWJ, Van Roy JLAM, Den Otter W, Van Eden W. Suppression of human cartilage proteoglycan synthesis by rheumatoid synovial fluid mononuclear cells activated with mycobacterial 60-kd heat-shock protein. Arthritis Rheum 1993;36:5-14-8.
37. Van Roon J, Van Roy JLAM, Duits AJ, Lafeber FPJG, Bijlsma JWJ. Proinflammatory cytokine production and cartilage damage due to RA synovial fluid T helper 1 activation is inhibited by IL-4. Ann Rheum Dis 1995;54:836-40.
38. Wilbrink B, Holewijn M, Bijlsma JWJ et al. Antigen-activated T cells inhibit cartilage proteoglycan synthesis independently of T-cell proliferation. Scand J Immunol 1992;36:733-43.
39. Schmidt J, Fleißner S, Heimann-Weitschat I et al. Effect of corticosteroids, cyclosporin A, and methotrexate on cytokine release from monocytes and T-cell subsets. Immunopharmacology 1994;27:173-9.
40. May KP, West SG, McDermott MT, Huffer WE. The effect of low-dose methotrexate on bone metabolism and histomorphometry in rats. Arthritis Rheum 1994;37:201-6.
41. Friedlaender GE, Tross RB, Doganis AC, Kirkwood JM, Baron R. Effects of chemotherapeutic agents on bone. I. Short-term methotrexate and doxorubicin (adriamycin) treatment in a rat model. J Bone Joint Surg 1984;66A:602-7.
42. Katz JN, LeBoff MS, Wade JP, Brown EM, Liang MH. Effect of methotrexate on bone density and calcium homeostasis in rheumatoid arthritis. Clin Res 1989;37:509A.